Panretin European Union - English - EMA (European Medicines Agency)

panretin

eisai gmbh - alitretinoin - sarcoma, kaposi - antineoplastic agents - panretin gel is indicated for the topical treatment of cutaneous lesions in patients with acquired-immune-deficiency-syndrome (aids)-related kaposi's sarcoma (ks) when:lesions are not ulcerated or lymphoedematous, and;treatment of visceral ks is not required, and;lesions are not responding to systemic antiretroviral therapy, and;radiotherapy or chemotherapy are not appropriate.

Fycompa 2 mg film-coated tablets European Union - English - myHealthbox

fycompa 2 mg film-coated tablets

eisai europe limited - perampanel - film-coated tablet - 2 mg - epilepsies, partial - antiepileptics, other antiepileptics - indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older

Fycompa 4 mg film-coated tablets European Union - English - myHealthbox

fycompa 4 mg film-coated tablets

eisai europe limited - perampanel - film-coated tablets - 4 mg - epilepsies, partial - antiepileptics, other antiepileptics - indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older

Fycompa 6 mg film-coated tablets European Union - English - myHealthbox

fycompa 6 mg film-coated tablets

eisai europe limited - perampanel - film-coated tablet - 6 mg - epilepsies, partial - antiepileptics, other antiepileptics - indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older

Fycompa 8 mg film-coated tablets European Union - English - myHealthbox

fycompa 8 mg film-coated tablets

eisai europe limited - perampanel - film-coated tablet - 8 mg - epilepsies, partial - antiepileptics, other antiepileptics - indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older

Fycompa 10 mg film-coated tablets European Union - English - myHealthbox

fycompa 10 mg film-coated tablets

eisai europe limited - perampanel - film-coated tablet - 10 mg - epilepsies, partial - antiepileptics, other antiepileptics - indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older

Fycompa 12 mg film-coated tablets European Union - English - myHealthbox

fycompa 12 mg film-coated tablets

eisai europe limited - perampanel - film-coated tablet - 12 mg - epilepsies, partial - antiepileptics, other antiepileptics - indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older

Dayvigo 5mg Film coated tablet Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dayvigo 5mg film coated tablet

eisai (malaysia) sdn bhd (18039-d) - lemborexant -

Dayvigo 10mg Film coated tablet Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dayvigo 10mg film coated tablet

eisai (malaysia) sdn bhd (18039-d) - lemborexant -

Fycompa European Union - English - EMA (European Medicines Agency)

fycompa

eisai gmbh - perampanel - epilepsies, partial - antiepileptics, , other antiepileptics - fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in adult and adolescent patients from 12 years of age with epilepsy.fycompa is indicated for the adjunctive treatment of primary generalised tonic-clonic seizures in adult and adolescent patients from 12 years of age with idiopathic generalised epilepsy.